Puma shares pop 13% after report China's Anta Sports is looking to buy the sportswear giant China's Anta Sports is among a number of firms looking to buy the German athletic brand, according to a media report. cnbc.com cnbc.com / feeds cnbc-com-top .. cnbc-com-world .. cnbc-com-retail .. cnbc-com-europe / / #news / / 24 days 24d Share
Europe's slow and steady approach to AI could be its edge Grid congestion and tough sustainability regulations are barriers to a rapid AI built-out, but these challenges benefit Europe in the long-run. cnbc.com cnbc.com / feeds cnbc-com-top .. cnbc-com-europe .. cnbc-com-world .. cnbc-com-entertainment .. cnbc-com-technology .. cnbc-com-energy / / #news / / 24 days 24d Share
Why Medicare price negotiations matter for Novo Nordisk, AstraZeneca, and other European pharma companies Pharma companies are facing pricing pressure from several directions, including from the U.S. Medicare negotiations ... cnbc.com cnbc.com / feeds cnbc-com-top .. cnbc-com-world .. cnbc-com-europe / / #news / / 25 days 25d Share
UK government borrowing costs fall as official economics forecasts released early The Autumn Budget is due to be announced shortly. cnbc.com cnbc.com / feeds cnbc-com-top .. cnbc-com-world .. cnbc-com-entertainment .. cnbc-com-europe / / #news / / 25 days 25d Share
CNBC's UK Exchange newsletter: History lessons for Reeves ahead of UK's much-hyped Budget Only a handful of Budgets from the last 45 years or so remain well-remembered by the wider public -- and not always for good reason. cnbc.com cnbc.com / feeds cnbc-com-world .. cnbc-com-europe / / #news / / 25 days 25d Share
Ukraine desperate to keep Trump onside in peace talks, while saving its sovereignty Talks between U.S. and Ukrainian officials were held this weekend after it emerged that Russia and the White House had secretly devised a peace plan. cnbc.com cnbc.com / feeds cnbc-com-world .. cnbc-com-top .. cnbc-com-europe / / #news / / 27 days 27d Share
Novo Nordisk shares plunge 10% after Alzheimer's drug trial fails to hit key target Shares of Novo Nordisk on Monday fell 10% after the Danish drug pharmaceutical company said a highly-anticipated trial for Alzheimer's disease failed to meet its main goal. cnbc.com cnbc.com / feeds cnbc-com-top .. cnbc-com-europe .. cnbc-com-world .. cnbc-com-entertainment .. cnbc-com-health-care / / #news / / 27 days 27d Share